KNOW YOUR PRODUCT

The important details, first.

RECONSTITUTION

Vial size + diluent

Vial sizeDiluent / amountFinal concentration
15 mg1.5 mL BAC water10 mg/mL
Reconstitution syringe: Use a 3 cc syringe to measure and add bacteriostatic water. The U-100 insulin syringe is used only afterward for drawing and administering the prepared dose at the unit mark listed in the dosing table.

QUICK REFERENCE

Frequency, site, cycle, and timing

ItemGuidanceNotes
Dose range0.5–12 mgTitrated protocol reference.
FrequencyOnce weeklyLong-term titrated reference.
DurationLong-term (titrated)Follow the selected titration structure.
Mix ratio15 mg : 1.5 mL BAC waterExact mix ratio.

DOSING + ADMINISTRATION

ALLU protocol reference

Phase / weekDoseFrequencyAdministration / U-100 draw
Conservative · Weeks 1–50.5 mgOnce weekly5 units.
Conservative · Weeks 6–101 mgOnce weekly10 units.
Conservative · Weeks 11–152 mgOnce weekly20 units.
Conservative · Weeks 16+3 mgOnce weekly30 units.
Clinical-style · Weeks 1–42 mgOnce weekly20 units.
Clinical-style · Weeks 5–84 mgOnce weekly40 units.
Clinical-style · Weeks 9–126 mgOnce weekly60 units.
Clinical-style · Weeks 13–169 mgOnce weekly90 units.
Clinical-style · Weeks 17+12 mgOnce weekly120 units.
Administration syringe: U-100 insulin syringe units shown in this table apply to drawing and administering the prepared dose only. Do not use these unit markings to determine the bacteriostatic-water amount for reconstitution.

MEASURING GUIDE

Volume and syringe conversion

ReferenceVolumeEquivalent
1 unit0.01 mL0.1 mg

VIALS NEEDED

Protocol planning

DurationVials needed
4 weeks1–2 vials
8 weeks2–3 vials
12 weeks3–5 vials
16 weeks4–6 vials
Vial counts are calculated from the dosing schedule shown above and rounded up to whole vials. They are planning estimates and do not include extra allowance for wastage.

STORAGE

How to keep it correctly.

Storage itemDirectionNotes
LyophilizedStore frozen at –20 °CProtocol storage.
After reconstitution2–8 °CUse within 2–4 weeks.

ADMINISTRATION

Where, when, and how.

ItemGuidanceNotes
RouteSubcutaneousProtocol route.
SyringeU-100 insulin syringe1 unit = 0.01 mL = 0.1 mg.
FrequencyOnce weeklyFollow the selected titration approach.
High-volume row120 units = 1.20 mL totalThis reproduces the verified protocol value. Confirm the appropriate administration device and volume with a qualified clinician rather than assuming it fits in one U-100 syringe.
Do not guess syringe units.

Syringe units measure volume, not milligrams. The correct draw amount changes when the vial strength or reconstitution volume changes.

06

SAFETY

Know when not to guess.

Talk to a doctor first when...

  • You have an existing medical condition or take regular medication.
  • You are pregnant, breastfeeding, trying to conceive, or unsure about suitability.
  • You have a history of significant allergic reactions or product-specific contraindications.
  • You are considering combining products or changing your dose.

PERSONAL GUIDANCE

Want someone to guide you through it?

ALLU can connect you with a doctor for a paid consultation focused on your health history, medications, goals, concerns, and questions.

Talk to a Doctor
07

FAQ + RESEARCH

Only the questions that help.

Where does PepTalk information come from?+

ALLU organizes product reference material, available research, and safety information into one easier-to-read guide. Information should be verified against the specific product and current evidence before being used as personal medical guidance.

What if my question is not answered here?+

For product or order questions, contact ALLU support. For personal medical questions, suitability, symptoms, interactions, or dose decisions, use the doctor consultation option.

Can I copy someone else's protocol?+

No. A protocol that suits another person may not be appropriate for you, and vial strengths or preparation methods can differ. Use information that matches your exact product and seek individualized guidance when needed.

Research & references+

PepTalk is designed to separate established clinical information from research-stage or community information. The full reference layer will be added as each product guide is validated.